Roselabs Bioscience Ltd and Roselabs Polymers Ltd is planning to invest Rs. 4000 million to manufacture pre-filled syringes in India. The method of using pre-filled syringe is designed to provide assured sterility, safety, convenience, greater accuracy, minimal over-filling, least medical waste, freedom from needle phobia and least chances of accidental needle stick injuries. The company has the capacity to manufacture 8 lakh syringes daily. Currently, 95% of pre-filled syringes are imported.Latest News :
The company is in the process of raising Rs. 1000 million towards private equity placements and venture capital
CKS Pharma Labs Pvt Ltd to set up a bulk drug unit in Jaggayapet in Krishna district of Andhra Pradesh with an investment of Rs. 42 million. The project involves setting up of a bulk drug unit to produce Pantoprazole Sodium, Carvedilol, Lansoprazole,Prasugrel Hydrochloride, LevoCetrizine Dihydrochloride, Lamotrigine, Lamivudine, Fluconazole etc., and will have a total capacity of 15.20 mtpm.
Indo Phyto Chemicals is to expand its bulk drug unit in Shakanpur in Pirumadara in Nainital in Uttarakhand with an investment of Rs. 50 million. The project involves expanding its bulk drug unit to produce Estradiol, Levonorgestrel, Norethisterone, Allylestrenol, Lynestrenol, Nandrolone Decanoate, ThiopentalSodium, Spironolactone, Solnaftate,Disulfiram etc., and will have a total capacity of 140000 kg /year .